Press Releases on August 6, 2020 - EIN Presswire - Press Release Distribution Service

Published on August 6, 2020 - 20:01 GMT

TPI Composites, Inc. Appoints James Hilderhoff as Chief Commercial Officer

SCOTTSDALE, Ariz., Aug. 06, 2020 (GLOBE NEWSWIRE) -- TPI Composites, Inc., (TPI) (Nasdaq: TPIC), the only independent manufacturer of composite wind blades with a global footprint, announced today that it has hired James Hilderhoff as its Chief Commercial …

Distribution channels: Companies, Consumer Goods ...

Published on August 6, 2020 - 20:01 GMT

Ross Stores Announces Second Quarter 2020 Earnings Release and Conference Call

Dublin, California, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Dublin, California -- Ross Stores, Inc. (NASDAQ: ROST) will announce its second quarter 2020 earnings results on Thursday, August 20, 2020. A press release will be sent out at approximately 4:00 p.m. …

Distribution channels: Media, Advertising & PR, Retail ...

Published on August 6, 2020 - 20:01 GMT

Editas Medicine Regains Full Global Rights to Ocular Medicines

CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced it has regained full global rights to research, develop, manufacture, and commercialize its ocular medicines, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 6, 2020 - 20:01 GMT

Iovance Biotherapeutics Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

SAN CARLOS, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL and peripheral-blood lymphocyte, …

Distribution channels:

Published on August 6, 2020 - 20:01 GMT

Capricor Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Exosome Platform for COVID-19 -Novel Multivalent Exosome mRNA and VLP Vaccine Candidates Underway in Animal Studies- -Preclinical Data Shows Positive Antibody Response- CAP-1002 for COVID-19 -Expanded Access Emergency Use Series Published in Peer Reviewed …

Distribution channels: Business & Economy, Technology ...

Published on August 6, 2020 - 20:01 GMT

Xenon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

XEN496 Phase 3 Protocol Submitted to FDA and Trial Initiation Anticipated in 2020 Conference Call at 4:30 pm ET Today BURNABY, British Columbia, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused …

Distribution channels:

Published on August 6, 2020 - 20:01 GMT

Celldex Provides Corporate Update and Reports Second Quarter 2020 Results

HAMPTON, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2020. The Company will host a conference call at 4:30 p.m. ET today to provide …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2020 - 20:01 GMT

DraftKings Expands Exclusive Partnership with Major League Baseball

BOSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) -- DraftKings Inc. (Nasdaq: DKNG) and Major League Baseball today announced a multi-year extension to remain the Official and Exclusive Daily Fantasy Sports (DFS) Partner of the League. The extension includes an …

Distribution channels: Companies, Travel & Tourism Industry ...

Published on August 6, 2020 - 20:01 GMT

Delcath Schedules Conference Call to Report 2020 Second Quarter Financial Results

NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of rare primary and metastatic cancers, today announced that it will host a conference call on August …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2020 - 20:01 GMT

FibroGen Announces New Appointments to its Board of Directors

- Appoints Aoife Brennan, M.B., B.Ch., President and CEO of Synlogic Inc. (NASDAQ:SYBX) - - Appoints Ben Cravatt, Ph.D., Professor and the Norton B. Gilula Chair of Chemical Biology in the Department of Chemistry at The Scripps Research Institute - SAN …

Distribution channels: Companies, Technology ...

Published on August 6, 2020 - 20:01 GMT

Satsuma Pharmaceuticals Announces Enrollment of First Patient in the ASCEND™ Phase 3 open-label, safety trial of STS101

ASCEND results expected to support STS101 NDA filing in Q4 2021 SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today announced the initiation of …

Distribution channels: Media, Advertising & PR, Technology ...

Published on August 6, 2020 - 20:01 GMT

Acorn, Provider of Remote Monitoring & Control IoT Solutions for Generators, Pipelines, Compressors and Other Critical Assets, ...

WILMINGTON, Del., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control systems and Internet of Things (IoT) services for stand-by generators, pipelines, air compressors and other critical …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on August 6, 2020 - 20:01 GMT

Nabriva Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates

-SIVEXTRO® adds revenue generating product creating additional scale and synergies- -Relaunch of XENLETA® and SIVEXTRO planned with targeted in-person promotion- -Conference call today at 4:30 p.m. Eastern Time- DUBLIN, Ireland, Aug. 06, 2020 (GLOBE …

Distribution channels:

Published on August 6, 2020 - 20:01 GMT

PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance

Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenue Net new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue $729.9 million of total revenue; representing a decrease of 4.4% at …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2020 - 20:01 GMT

Celyad Oncology Reports Half Year 2020 Financial Results and Second Quarter Business Highlights

Interim analysis from alloSHRINK Phase 1 trial demonstrated mPFS of 3.9 months for mCRC patients with MSS disease treated with CYAD-101 following FOLFOX preconditioning; expansion cohort of alloSHRINK trial on-track to begin by fourth quarter 2020 Phase 1 …

Distribution channels:

Published on August 6, 2020 - 20:01 GMT

Vaxart Announces Second Quarter 2020 Results

Enhanced Leadership – New CEO in Q2 Ample Cash Runway following Financing by Notable Institutional Healthcare Investors SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral …

Distribution channels: Media, Advertising & PR, Technology ...

Published on August 6, 2020 - 20:00 GMT

STRATTEC SECURITY CORPORATION Reports Fiscal 2020 Fourth Quarter and Full Year Operating Results

MILWAUKEE, Aug. 06, 2020 (GLOBE NEWSWIRE) -- STRATTEC SECURITY CORPORATION (NASDAQ:STRT) today reported operating results for the fiscal fourth quarter and full year ended June 28, 2020. The fourth quarter operating results were significantly impacted by …

Distribution channels: Automotive Industry, Business & Economy ...

Published on August 6, 2020 - 20:00 GMT

Apollo Investment Corporation Reports Financial Results for the Quarter Ended June 30, 2020

Fiscal First Quarter and Other Recent Highlights: Net investment income per share for the quarter was $0.43 compared to $0.59 for the quarter ended March 31, 2020 Net asset value per share as of the end of the quarter was $15.29 compared to $15.70 as of …

Distribution channels:

Published on August 6, 2020 - 20:00 GMT

PDF Solutions® Reports Second Quarter 2020 Results

Business Highlights Total revenues of $21.4 million, up 4% over last year’s comparable quarter Analytics revenue of $15.2 million, up 27% over last year’s comparable quarter Analytics accounted for 71% of second quarter revenues GAAP Gross Margin of 58% …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on August 6, 2020 - 20:00 GMT

Cytokinetics Reports Second Quarter 2020 Financial Results

Top-line Results from GALACTIC-HF Expected in Q4 2020 Licensing Collaboration, Royalty Monetizations and Financing Provide Additional Capital to Support Commercial Development and Pipeline Expansion; Company Expects to End 2020 With More Than $500 Million …

Distribution channels: